Fate Therapeutics Inc (FATE)
2.07
-0.15
(-6.76%)
USD |
NASDAQ |
Nov 21, 16:00
2.07
0.00 (0.00%)
Pre-Market: 08:35
Fate Therapeutics Shareholders Equity (Quarterly): 362.33M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 362.33M |
| June 30, 2024 | 396.98M |
| March 31, 2024 | 426.12M |
| December 31, 2023 | 368.42M |
| September 30, 2023 | 402.78M |
| June 30, 2023 | 437.76M |
| March 31, 2023 | 477.47M |
| December 31, 2022 | 483.94M |
| September 30, 2022 | 518.00M |
| June 30, 2022 | 580.48M |
| March 31, 2022 | 633.39M |
| December 31, 2021 | 678.84M |
| September 30, 2021 | 730.33M |
| June 30, 2021 | 752.07M |
| March 31, 2021 | 790.10M |
| December 31, 2020 | 384.44M |
| September 30, 2020 | 424.36M |
| June 30, 2020 | 474.11M |
| March 31, 2020 | 219.22M |
| December 31, 2019 | 244.76M |
| September 30, 2019 | 268.04M |
| June 30, 2019 | 127.53M |
| March 31, 2019 | 145.84M |
| December 31, 2018 | 160.47M |
| Date | Value |
|---|---|
| September 30, 2018 | 173.93M |
| June 30, 2018 | 51.82M |
| March 31, 2018 | 65.00M |
| December 31, 2017 | 77.19M |
| September 30, 2017 | 45.75M |
| June 30, 2017 | 55.21M |
| March 31, 2017 | 63.86M |
| December 31, 2016 | 73.15M |
| September 30, 2016 | 25.37M |
| June 30, 2016 | 23.13M |
| March 31, 2016 | 30.73M |
| December 31, 2015 | 38.04M |
| September 30, 2015 | 45.00M |
| June 30, 2015 | 51.07M |
| March 31, 2015 | 21.25M |
| December 31, 2014 | 28.34M |
| September 30, 2014 | 33.58M |
| June 30, 2014 | 39.64M |
| March 31, 2014 | 45.18M |
| December 31, 2013 | 50.85M |
| September 30, 2013 | -66.40M |
| June 30, 2013 | -0.15M |
| December 31, 2012 | -52.82M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
219.22M
Minimum
Mar 2020
790.10M
Maximum
Mar 2021
489.29M
Average
455.93M
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
| Oragenics Inc | 3.078M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 494.97M |
| Total Liabilities (Quarterly) | 132.64M |
| Current Ratio | 8.292 |